PHASE II STUDY OF AMRUBICIN FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER AS THIRD-LINE OR FOURTH-LINE CHEMOTHERAPY: UPDATED RESULTS
Satoshi Oizumi,Toshiyuki Harada,Kenichiro Ito,Kei Takamura,Tomoya Kuda,Shunichi Sugawara,Kana Watanabe,Makoto Maemondo,Yuka Fujita,Ichiro Kinoshita,Akira Inoue,Fumihiro Hommura,Yutaka Katsuura,Hirotoshi Akita,Hiroshi Isobe,Masaharu Nishimura RESPIROLOGY（2013）
AI 理解论文
溯源树
样例
